Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Post Holdings Q1 2026 Earnings Strong EPS Beat Masks Mixed Underlying Performance UFCS Q1 2026 Earnings EPS Surges Past Estimates with 37 Beat DT Midstream Q1 2026 Earnings Earnings Beat Estimates by Nearly 10 APC Q1 2026 Earnings EPS Beats Estimates Amid Revenue NonDisclosure Stock Slides SJM Q1 2026 Earnings EPS Exceeds Consensus Shares Move Higher